Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1382-1389

  Legrand, Eric ^a   Yrinesi, Joséphine ^a   Ekala, Marie Thérèse ^b   Péneau, Julie ^a   Volney, Béatrice ^a   Berger, Franck ^a   Bouchier, Christiane ^b   Bertani, Stéphane ^a   Musset, Lise ^a   Meynard, Jean Baptiste ^a   Mercereau Puijalon, Odile ^b  

^a INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; HALOFANTRINE; MEFLOQUINE; PFCRT PROTEIN; PFMDR1 PROTEIN; PROTOZOAL PROTEIN; QUININE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG CONTROL; DRUG POLICY; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG WITHDRAWAL; FRENCH GUIANA; GENE DOSAGE; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; IC 50; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

AMINOQUINOLINES; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG COMBINATIONS; DRUG RESISTANCE; ETHANOLAMINES; EVOLUTION, MOLECULAR; FLUORENES; FRENCH GUIANA; GENE DOSAGE; HAPLOTYPES; HUMANS; INHIBITORY CONCENTRATION 50; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MEFLOQUINE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PARASITIC SENSITIVITY TESTS; PHENANTHRENES; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINES AS TOPIC; PROTOZOAN PROTEINS; QUININE;

EID: 84857163350     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05280-11     Document Type: Article

References (44)

1. Ariey F, et al. 2006. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar. J. 5:34.
2. Bacon DJ, et al. 2009. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob. Agents Chemother. 53: 2042-2051.
3. Baliraine FN, et al. 2011. Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. Antimicrob. Agents Chemother. 55: 615-622.
4. Best Plummer W, Pinto Pereira LM, Carrington CV. 2004. Pfcrt and pfmdr1 alleles associated with chloroquine resistance in Plasmodium falciparum from Guyana, South America. Mem. Inst. Oswaldo Cruz 99:389-392. (Pubitemid 38952477)
5. Carme B, et al. 2009. Update on the epidemiology of malaria in French Guiana. Med. Trop. 69:19-25.
6. Chaijaroenkul W, et al. 2011. Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparum. Malar. J. 10:42.
7. Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K. 2010. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Acta Trop. 113:190-194.
8. Chen N, et al. 2010. Deamplification of pfmdr1-containing amplicon on chromosome 5 in Plasmodium falciparum is associated with reduced resistance to artelinic acid in vitro. Antimicrob. Agents Chemother. 54: 3395-3401.
9. Cojean S, et al. 2006. Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa. Malar. J. 5:24.
10. Cowman AF, Galatis D, Thompson JK. 1994. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. U. S. A. 91:1143-1147. (Pubitemid 24048525)
11. Danquah I, et al. 2010. Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso. Acta Trop. 114: 63-66.
12. Das MK, et al. 2010. High chloroquine treatment failure rates and pre-dominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India. J. Antimicrob. Chemother. 65:1258-1261.
13. Djimdé A, et al. 2001. A molecular marker for chloroquine- resistant falciparum malaria. N. Engl. J. Med. 344:257-263. (Pubitemid 32108530)
14. Duraisingh MT, et al. 1997. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114:205-211. (Pubitemid 27135229)
15. Durrand V, et al. 2004. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. Mol. Biochem. Parasitol. 136:273-285. (Pubitemid 38757996)
16. Ekala MT, et al. 2007. Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites. Malar. J. 6:164.
17. Fidock DA, et al. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
18. Foote SJ, et al. 1990. Several alleles of the multidrug resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345:255-258.
19. Gama BE, et al. 2010. Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy. Malar. J. 9:355.
20. Griffing S, et al. 2010. pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrob. Agents Chemother. 54:1572-1579.
21. Holmgren G, et al. 2006. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect. Genet. Evol. 6:309-314. (Pubitemid 43785813)
22. Humphreys GS, et al. 2007. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother. 51:991-997. (Pubitemid 46355285)
23. Johnson DJ, et al. 2004. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell 15:867-877. (Pubitemid 39277984)
24. Khim N, et al. 2005. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob. Agents Chemother. 49:3147-3152. (Pubitemid 41060552)
25. Kimchi-Sarfaty C, et al. 2007. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315:525-528. (Pubitemid 46175758)
26. Laufer MK, et al. 2010. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J. Infect. Dis. 202:801-808.
27. Legrand E, et al. 2005. Molecular analysis of two local falciparum malaria outbreaks on the French Guiana coast confirms the msp1 B-K1/varD genotype association with severe malaria. Malar. J. 4:26.
28. Legrand E, Volney B, Meynard JB, Mercereau-Puijalon O, Esterre P. 2008. In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005. Antimicrob. Agents Chemother. 52:288-298.
29. Lim P, et al. 2009. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 8:11.
30. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408. (Pubitemid 34164012)
31. Mehlotra RK, et al. 2008. Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother. 52:2212-2222. (Pubitemid 351758561)
32. Mita T, et al. 2004. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol. Biochem. Parasitol. 135:159-163. (Pubitemid 38470086)
33. Nsobya SL, et al. 2010. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob. Agents Chemother. 54:1200-1206.
34. Peel SA, Bright P, Yount B, Handy J, Baric RS. 1994. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 51: 648-658. (Pubitemid 24378562)
35. Price RN, et al. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447. (Pubitemid 39036891)
36. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909. (Pubitemid 30130994)
37. Sá JM, et al. 2009. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc. Natl. Acad. Sci. U. S. A. 106:18883-18889.
38. Sanchez CP, Dave A, Stein WD, Lanzer M. 2010. Transporters as mediators of drug resistance in Plasmodium falciparum. Int. J. Parasitol. 40:1109-1118.
39. Sidhu AB, et al. 2006. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194:528-535. (Pubitemid 44162666)
40. Sidhu AB, Valderramos SG, Fidock DA. 2005. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57:913-926. (Pubitemid 41139856)
41. Sidhu AB, Verdier-Pinard D, Fidock DA. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
42. Valderramos SG, et al. 2010. Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS Pathog. 6:e1000887.
43. Vieira PP, et al. 2004. pfcrt polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon basin. J. Infect. Dis. 190:417-424. (Pubitemid 38951985)
44. Wang X, et al. 2005. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. Am. J. Trop. Med. Hyg. 72:410-414. (Pubitemid 41278849)